Cargando…

Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis

AIMS/HYPOTHESIS: Diabetes has been identified as a risk factor for poor prognosis of coronavirus disease-2019 (COVID-19). The aim of this study is to identify high-risk phenotypes of diabetes associated with COVID-19 severity and death. METHODS: This is the first edition of a living systematic revie...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlesinger, Sabrina, Neuenschwander, Manuela, Lang, Alexander, Pafili, Kalliopi, Kuss, Oliver, Herder, Christian, Roden, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079163/
https://www.ncbi.nlm.nih.gov/pubmed/33907860
http://dx.doi.org/10.1007/s00125-021-05458-8
_version_ 1783685165459963904
author Schlesinger, Sabrina
Neuenschwander, Manuela
Lang, Alexander
Pafili, Kalliopi
Kuss, Oliver
Herder, Christian
Roden, Michael
author_facet Schlesinger, Sabrina
Neuenschwander, Manuela
Lang, Alexander
Pafili, Kalliopi
Kuss, Oliver
Herder, Christian
Roden, Michael
author_sort Schlesinger, Sabrina
collection PubMed
description AIMS/HYPOTHESIS: Diabetes has been identified as a risk factor for poor prognosis of coronavirus disease-2019 (COVID-19). The aim of this study is to identify high-risk phenotypes of diabetes associated with COVID-19 severity and death. METHODS: This is the first edition of a living systematic review and meta-analysis on observational studies investigating phenotypes in individuals with diabetes and COVID-19-related death and severity. Four different databases were searched up to 10 October 2020. We used a random effects meta-analysis to calculate summary relative risks (SRR) with 95% CI. The certainty of evidence was evaluated by the GRADE tool. RESULTS: A total of 22 articles, including 17,687 individuals, met our inclusion criteria. For COVID-19-related death among individuals with diabetes and COVID-19, there was high to moderate certainty of evidence for associations (SRR [95% CI]) between male sex (1.28 [1.02, 1.61], n = 10 studies), older age (>65 years: 3.49 [1.82, 6.69], n = 6 studies), pre-existing comorbidities (cardiovascular disease: 1.56 [1.09, 2.24], n = 8 studies; chronic kidney disease: 1.93 [1.28, 2.90], n = 6 studies; chronic obstructive pulmonary disease: 1.40 [1.21, 1.62], n = 5 studies), diabetes treatment (insulin use: 1.75 [1.01, 3.03], n = 5 studies; metformin use: 0.50 [0.28, 0.90], n = 4 studies) and blood glucose at admission (≥11 mmol/l: 8.60 [2.25, 32.83], n = 2 studies). Similar, but generally weaker and less precise associations were observed between risk phenotypes of diabetes and severity of COVID-19. CONCLUSIONS/INTERPRETATION: Individuals with a more severe course of diabetes have a poorer prognosis of COVID-19 compared with individuals with a milder course of disease. To further strengthen the evidence, more studies on this topic that account for potential confounders are warranted. REGISTRATION: PROSPERO registration ID CRD42020193692. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-021-05458-8.
format Online
Article
Text
id pubmed-8079163
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-80791632021-04-28 Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis Schlesinger, Sabrina Neuenschwander, Manuela Lang, Alexander Pafili, Kalliopi Kuss, Oliver Herder, Christian Roden, Michael Diabetologia Article AIMS/HYPOTHESIS: Diabetes has been identified as a risk factor for poor prognosis of coronavirus disease-2019 (COVID-19). The aim of this study is to identify high-risk phenotypes of diabetes associated with COVID-19 severity and death. METHODS: This is the first edition of a living systematic review and meta-analysis on observational studies investigating phenotypes in individuals with diabetes and COVID-19-related death and severity. Four different databases were searched up to 10 October 2020. We used a random effects meta-analysis to calculate summary relative risks (SRR) with 95% CI. The certainty of evidence was evaluated by the GRADE tool. RESULTS: A total of 22 articles, including 17,687 individuals, met our inclusion criteria. For COVID-19-related death among individuals with diabetes and COVID-19, there was high to moderate certainty of evidence for associations (SRR [95% CI]) between male sex (1.28 [1.02, 1.61], n = 10 studies), older age (>65 years: 3.49 [1.82, 6.69], n = 6 studies), pre-existing comorbidities (cardiovascular disease: 1.56 [1.09, 2.24], n = 8 studies; chronic kidney disease: 1.93 [1.28, 2.90], n = 6 studies; chronic obstructive pulmonary disease: 1.40 [1.21, 1.62], n = 5 studies), diabetes treatment (insulin use: 1.75 [1.01, 3.03], n = 5 studies; metformin use: 0.50 [0.28, 0.90], n = 4 studies) and blood glucose at admission (≥11 mmol/l: 8.60 [2.25, 32.83], n = 2 studies). Similar, but generally weaker and less precise associations were observed between risk phenotypes of diabetes and severity of COVID-19. CONCLUSIONS/INTERPRETATION: Individuals with a more severe course of diabetes have a poorer prognosis of COVID-19 compared with individuals with a milder course of disease. To further strengthen the evidence, more studies on this topic that account for potential confounders are warranted. REGISTRATION: PROSPERO registration ID CRD42020193692. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-021-05458-8. Springer Berlin Heidelberg 2021-04-28 2021 /pmc/articles/PMC8079163/ /pubmed/33907860 http://dx.doi.org/10.1007/s00125-021-05458-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Schlesinger, Sabrina
Neuenschwander, Manuela
Lang, Alexander
Pafili, Kalliopi
Kuss, Oliver
Herder, Christian
Roden, Michael
Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
title Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
title_full Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
title_fullStr Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
title_full_unstemmed Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
title_short Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
title_sort risk phenotypes of diabetes and association with covid-19 severity and death: a living systematic review and meta-analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079163/
https://www.ncbi.nlm.nih.gov/pubmed/33907860
http://dx.doi.org/10.1007/s00125-021-05458-8
work_keys_str_mv AT schlesingersabrina riskphenotypesofdiabetesandassociationwithcovid19severityanddeathalivingsystematicreviewandmetaanalysis
AT neuenschwandermanuela riskphenotypesofdiabetesandassociationwithcovid19severityanddeathalivingsystematicreviewandmetaanalysis
AT langalexander riskphenotypesofdiabetesandassociationwithcovid19severityanddeathalivingsystematicreviewandmetaanalysis
AT pafilikalliopi riskphenotypesofdiabetesandassociationwithcovid19severityanddeathalivingsystematicreviewandmetaanalysis
AT kussoliver riskphenotypesofdiabetesandassociationwithcovid19severityanddeathalivingsystematicreviewandmetaanalysis
AT herderchristian riskphenotypesofdiabetesandassociationwithcovid19severityanddeathalivingsystematicreviewandmetaanalysis
AT rodenmichael riskphenotypesofdiabetesandassociationwithcovid19severityanddeathalivingsystematicreviewandmetaanalysis